Mitchell Sinkler & Starr Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$4.14M |
| 2 |
Microsoft
MSFT
|
+$3.35M |
| 3 |
Eli Lilly
LLY
|
+$3.19M |
| 4 |
Johnson & Johnson
JNJ
|
+$2.91M |
| 5 |
Home Depot
HD
|
+$2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Broad Market ETF
SCHB
|
+$5.52M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
+$5.09M |
| 3 |
Union Pacific
UNP
|
+$3.61M |
| 4 |
JPMorgan Chase
JPM
|
+$3.49M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23% |
| 2 | Healthcare | 19.07% |
| 3 | Consumer Staples | 11.18% |
| 4 | Financials | 10% |
| 5 | Industrials | 9.83% |
Similar funds
Mitchell Sinkler & Starr's Q3 2023 Portfolio in Review
As of Q3 2023, Mitchell Sinkler & Starr held 144 positions worth $325M, down 7.7% from $352M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Mitchell Sinkler & Starr withdrew a net $14.6M in Q3 2023, closing 39 positions and reducing 15 holdings. Its most notable exit was Schwab US Broad Market ETF, an estimated $5.52M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Mitchell Sinkler & Starr opened a new position in Kenvue worth $771K.
- Mitchell Sinkler & Starr's largest Q3 2023 buy was Kenvue: 38,407 shares worth $771K.
- Mitchell Sinkler & Starr added most to Merck in Q3 2023, an estimated $4.14M increase.
- Mitchell Sinkler & Starr's biggest Q3 2023 reduction was Union Pacific, cutting an estimated $3.61M.
- Mitchell Sinkler & Starr fully exited Schwab US Broad Market ETF in Q3 2023, selling an estimated $5.52M.
- Mitchell Sinkler & Starr's ten largest holdings make up 42% of its $325M portfolio in Q3 2023.
- Mitchell Sinkler & Starr opened 5 new positions and closed 39 in Q3 2023.
- Mitchell Sinkler & Starr's portfolio value fell 7.7% quarter-over-quarter to $325M.
Based on Mitchell Sinkler & Starr's 13F filing for Q3 2023, filed 1 Nov 2023.